Reaktionsgleichung
C(OC([N:8]1[CH2:12][CH2:11][S:10][CH:9]1[C:13]([OH:15])=O)=O)(C)(C)C.[CH:16]1[CH:21]=[CH:20][C:19](/[C:22](/C2C=CC([N+]([O-])=O)=CC=2)=[N:23]/O)=[CH:18][CH:17]=1.[C:34]1([C:44]2[CH:49]=[CH:48][CH:47]=[CH:46][CH:45]=2)[CH:39]=[CH:38][C:37]([S:40](Cl)(=[O:42])=[O:41])=[CH:36][CH:35]=1.C(N)C1C=CC=CC=1>>[CH2:22]([NH:23][C:13]([CH:9]1[N:8]([S:40]([C:37]2[CH:38]=[CH:39][C:34]([C:44]3[CH:49]=[CH:48][CH:47]=[CH:46][CH:45]=3)=[CH:35][CH:36]=2)(=[O:42])=[O:41])[CH2:12][CH2:11][S:10]1)=[O:15])[C:19]1[CH:20]=[CH:21][CH:16]=[CH:17][CH:18]=1Komponenten
5
Versuchsvorschrift
Following the general solid phase method as outlined Example 33, starting from 3-(tert-butoxycarbonyl)-1,3-thiazolidine-2-carboxylic acid, Kaiser oxime resin, [1,1′-biphenyl]-4-sulfonyl chloride and benzylamine, the title compound was obtained in 97% purity by HPLC.
Quellen und Nachweise
- ORD-Eintrag
- ord-d1851bea5c0242b798ec49dd5bd56cde
- Quelldatensatz
- uspto-grants-2013_04
- Patentnummer
- US08415480B2
Verknüpfte Notizen
Wird geladen…